Search hospitals > Wisconsin > Oconto Falls
Saint Vincent Hospital Cancer Center at Oconto Falls
Claim this profileOconto Falls, Wisconsin 54154
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Recurrence
Conducts research for Non-Small Cell Lung Cancer
285 reported clinical trials
4 medical researchers
Summary
Saint Vincent Hospital Cancer Center at Oconto Falls is a medical facility located in Oconto Falls, Wisconsin. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Non-Small Cell Lung Cancer and other specialties. Saint Vincent Hospital Cancer Center at Oconto Falls is involved with conducting 285 clinical trials across 420 conditions. There are 4 research doctors associated with this hospital, such as Matthew L. Ryan, Brian L. Burnette, Anthony J. Jaslowski, and Catherine A. Long.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Breast Cancer
Global LeaderStage IV
ER positive
HER2 negative
Top PIs
Matthew L. RyanSaint Vincent Hospital Cancer Center Green Bay1 year of reported clinical research
Expert in Cancer
Studies Recurrence
45 reported clinical trials
103 drugs studied
Brian L. BurnetteSaint Vincent Hospital Cancer Center Green Bay4 years of reported clinical research
Expert in Cancer
Studies Breast Cancer
27 reported clinical trials
77 drugs studied
Anthony J. JaslowskiSaint Vincent Hospital Cancer Center Green Bay5 years of reported clinical research
Studies Cancer
Studies Breast Cancer
20 reported clinical trials
37 drugs studied
Catherine A. LongSaint Vincent Hospital Cancer Center Green Bay4 years of reported clinical research
Studies Tumors
Studies Cancer
21 reported clinical trials
56 drugs studied
Clinical Trials running at Saint Vincent Hospital Cancer Center at Oconto Falls
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Cancer
Diffuse Large B-Cell Lymphoma
Melanoma
Lymphoma
Colorectal Cancer
Recurrence
Ovarian Tumors
Chemotherapy + Hormone Therapy
for Breast Cancer
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint Ultrahigh (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint Ultrahigh Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Support Program
for Breast Cancer
This study is evaluating whether a support program may help breast cancer patients take their medication correctly.
Recruiting2 awards Phase 34 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Saint Vincent Hospital Cancer Center at Oconto Falls?
Saint Vincent Hospital Cancer Center at Oconto Falls is a medical facility located in Oconto Falls, Wisconsin. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Non-Small Cell Lung Cancer and other specialties. Saint Vincent Hospital Cancer Center at Oconto Falls is involved with conducting 285 clinical trials across 420 conditions. There are 4 research doctors associated with this hospital, such as Matthew L. Ryan, Brian L. Burnette, Anthony J. Jaslowski, and Catherine A. Long.